GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to prioritize global health R&D in the fiscal year 2017 (FY17) budget.
GHTC sent a letter to all 535 Members of Congress, urging them to commit to a long-term vision for financing global health research that ensures we have the tools necessary to treat both endemic and emerging diseases, like Zika.
GHTC sent a letter to the UN Secretary General and submitted evidence to the High-Level Panel (HLP) urging them to incorporate the experience of product development partnerships (PDPs), which demonstrate a variety of barriers to access to health technologies.
GHTC sent a letter welcoming incoming Administrator of the US Agency for International Development (USAID) Gayle Smith, highlighting the agency’s work on global health R&D and urging her to continue to support this work as administrator.